Meet the startup using dogs to sniff out cancer

The latest stories trending on MedCity News.

Editor's Pick

Top Story Meet the Startup Using Dogs to Sniff Out Cancer Israeli cancer diagnostics startup SpoititEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients' breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year. Sponsored The Best Way to Manage Migraines Without Medication Presented by Cefaly For many people, migraines interfere with daily life, work and relationships. Understanding what's behind them — and how to manage them naturally — can be a powerful step toward lasting relief. Learn More INVEST Chicago is Next Week, Get Your Ticket Now! INVEST 2025 Chicago - "Where Capital Meets Innovation." Join us May 20-21 at Willis Tower for two days packed with the latest healthcare insights, startup pitches, and unparalleled networking opportunities. Reserve Your Ticket

Featured News

Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies [Sponsored] The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer. Medbridge Announces New AI-Powered Motion-Capture Capabilities for MSK With Medbridge's new motion capture capabilities, patients can get more accurate feedback on therapeutic exercises while using their mobile phone or computer's camera. AbbVie's Solid Tumor Strategy Gets a Win With Accelerated FDA Approval in Lung Cancer Emrelis, an antibody drug conjugate developed by AbbVie, is now FDA approved for patients whose non-small cell lung cancer overexpresses the protein c-Met. The pharma company said this ADC is its first internally developed solid tumor medicine as well as its first solid tumor FDA approval in lung cancer. AI Won't Save Healthcare, But It Can Help Stop Wasting Millions Despite what some may claim, AI will never replace doctors — but we could use AI to help improve the overall scaffolding that healthcare reimbursement runs on, decreasing costs and freeing up spending to focus on expenses directly tied to patient care activities. Imagine Reshaping The Surgical Landscape With Autonomous Surgery To prepare for an autonomous surgical future, medtech leaders should explore the practical implications of potential scenarios, and structure investment accordingly. The key is to develop a living roadmap that drives decisions on a day-by-day basis, drawing on macro- and micro-trends.

Video   Adding Up the Costs of Medicare Advantage Proponents of Medicare Advantage say that these plans are cost effective and help seniors pay less. However, the Medicare Payment Advisory Commission (MedPAC) — which advises Congress on Medicare policies — recently released a report showing that in 2025, CMS will have spent $84 million more on Medicare Advantage enrollees than if those same individuals were enrolled in traditional Medicare. Still, many seniors say that Medicare Advantage plans suit them better because of low premiums and out-of-pocket costs. So how does this all add up? The government is paying more for Medicare Advantage enrollees, yet these same enrollees are paying less — who makes up the difference?

Sponsored The Top Surgical Instruments Needed for Extractions Presented by ProDentUSA Discover what tools are essential for efficient, safe surgical extractions in today's health care landscape, from elevators to forceps and beyond. Learn More

Resources

MedCity FemFwd: Improving the Collection of Maternal Health Data In this episode, we're joined by Maggie McCullough, CEO of PolicyMap. She discusses what's wrong with the way maternal health data is collected at the federal level and ways it can be improved. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe